Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.

Payvandi F, Wu L, Naziruddin SD, Haley M, Parton A, Schafer PH, Chen RS, Muller GW, Hughes CC, Stirling DI

DOI: 10.1089/jir.2005.25.604
Published: 2005 Oct
Container: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1089/jir.2005.25.604,
  title = {Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.},
  author = {Payvandi F and Wu L and Naziruddin SD and Haley M and Parton A and Schafer PH and Chen RS and Muller GW and Hughes CC and Stirling DI},
  year = {2005},
  journal = {Journal of interferon \& cytokine research : the official journal of the International Society for Interferon and Cytokine Research},
  doi = {10.1089/jir.2005.25.604},
  url = {https://doi.org/10.1089/jir.2005.25.604}
}

RIS

TY  - JOUR
TI  - Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.
AU  - Payvandi F
AU  - Wu L
AU  - Naziruddin SD
AU  - Haley M
AU  - Parton A
AU  - Schafer PH
AU  - Chen RS
AU  - Muller GW
AU  - Hughes CC
AU  - Stirling DI
PY  - 2005
JO  - Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
DO  - 10.1089/jir.2005.25.604
UR  - https://doi.org/10.1089/jir.2005.25.604
ER  -

APA

F, P., L, W., SD, N., M, H., A, P., PH, S., RS, C., GW, M., CC, H., & DI, S. (2005). Immunomodulatory drugs (IMiDs) increase the production of IL-2 from stimulated T cells by increasing PKC-theta activation and enhancing the DNA-binding activity of AP-1 but not NF-kappaB, OCT-1, or NF-AT.. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. https://doi.org/10.1089/jir.2005.25.604

Source records

pubmed · retrieved 2026-09-25T05:44:33.934Z